Alembic Pharmaceuticals Limited (APLLTD) secures USFDA final approval for Venetoclax Tablets, 10 mg, 50 mg, and 100 mg, expanding its generic drug portfolio.
Sun Pharma's ILUMYA® gains FDA approval for treating psoriatic arthritis, expanding its therapeutic portfolio and benefits for patients.
Sudeep Pharma Limited (SUDEEPPHRM) receives FDA approval for new Gujarat facility, enabling manufacturing operations with 51,200 MT annual capacity.
Zydus Lifesciences Limited (ZYDUSLIFE) receives USFDA approval for Estradiol and Levonorgestrel Transdermal System, gaining 180-day CGT exclusivity.
Alembic Pharmaceuticals Limited (APLLTD) receives USFDA final approval for Ciprofloxacin and Dexamethasone Otic Suspension USP, expanding its generic drug po.
Lupin Limited (LUPIN) secures U.S. FDA approval for Modafinil Tablets, expanding its generics portfolio with a bioequivalent to Provigil®.
Lupin Limited (LUPIN) secures FDA approval for Sodium Zirconium Cyclosilicate Oral Suspension, expanding its therapeutic portfolio.
Dr. Reddy's Laboratories Ltd. (NSE: DRREDDY) receives FDA approval for its rituximab biosimilar, expanding its global biosimilars portfolio.
Lupin Limited (LUPIN) announces U.S. FDA approval and launch of Sugammadex Injection, a bioequivalent to Bridion®.
Alembic Pharmaceuticals Limited (APLLTD) secures USFDA final approval for Prucalopride Tablets, 1 mg and 2 mg, expanding its generic drug portfolio.